Higher Heart Attack Risk With NSAIDs May Come Early

While common OTC (over-the-counter) pain medications are known to carry a risk of heart attack, a new study finds that the risk can arise in as little as a week after starting the drugs.

NSAIDs (non-steroidal anti-inflammatory drugs), such as Advil (ibuprofen) and Aleve (naproxen), boosted the risk of a heart attack by between 20% and 50% compared with people who didn’t take them. And that higher risk was seen at any dose, whether taken for a week, a month or longer than a month, according to results reported in the BMJ.

In addition, the risk rose with higher doses. But researchers also noted that the risk is still quite small. Overall, the risk of heart attack due to NSAIDs is on average about 1%.

Canadian researchers conducted a meta-analysis that looked at data from studies on more than 447,000 people between the ages of 40 and 79. Of that number, 61,000 had a heart attack.

Of the medications the people were taking, they were most interested in ibuprofen, naproxen and another NSAID called Voltaren (diclofenac). They also examined two COX-2 inhibitors, also classified as NSAIDs, called Vioxx (rofecoxib) and Celebrex (celecoxib). Vioxx was pulled from the US market in 2004 amid concerns about the drug causing heart attacks and strokes.

“Given that the onset of risk of acute myocardial infarction occurred in the first week and appeared greatest in the first month of treatment with higher doses, prescribers should consider weighing the risks and benefits of NSAIDs before instituting treatment, particularly for higher doses,” the researchers concluded.


Jonathan Block

Jonathan Block

Jonathan Block is an associate editor at BioCentury, which provides news and information about the biotechnology and pharmaceutical industries. Prior to joining BioCentury in 2019, Jonathan worked for MedShadow as content editor. He has been an editor and writer for multiple pharmaceutical, health and medical publications, including The Pink Sheet, Modern Healthcare, Health Plan Week and Psychiatry Advisor. He holds a BA from Tufts University and is earning an MPH with a focus on health policy from the CUNY Graduate School of Public Health & Health Policy.


Did you find this article helpful?


Latest News

Belviq, ActiPatch, Free Samples, Dollar Tree Drugs

Belviq, ActiPatch, Free Samples, Dollar Tree Drugs

We knew it was too good to be true – free and cheap drugs aren’t worth it. Also, taking a magic pill to lose weight could give you cancer (!). One ray of sunshine: a pain therapy device using shortwave is now available over-the-counter. Have a lovely Valentine’s Day! Be…

Flouride, PPIs, Breast Density and Prostate Cancer

Flouride, PPIs, Breast Density and Prostate Cancer

Startling news about fluoride, a study encourages more limites use of PPIs, does knowing the density of your breasts matter, and vegetables aren’t helpful in warding off prostate cancer (darn).  Be Well.  Fluoride and Pregnancy The medical community was shocked at the conclusions of two new studies on fluoride’s effect…

  • Advertisement